ResourcesVendorsMolecular DiagnosticsbioMerieux100 Rodolphe Street Durham, NC, USA 27712Latest from bioMerieuxCandidiasisBioMérieux researchers describe rise of multidrug-resistant Candida auris infectionsBy Elissa WolfsonA retrospective analysis of blood cultures detecting Candida auris found an upsurge of this pathogenic yeast between 2021 and 2023.June 19, 2023Molecular DiagnosticsCOVID-19 testing boosts molecular point-of-care marketBy Bruce CarlsonMolecular POC diagnostic solutions offer improvements in the sensitivity and specificity of existing near-patient and rapid tests while expanding the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world, and are used to assess conditions or admit patients. The concept of mPOC is to combine the accessibility of POC testing with the accuracy of molecular technology. Disclosure: LabPulse.com is a sister company of Kalorama Information.January 26, 2021ConsumerTop companies earn 80% of revenue in IVD marketBy Bruce CarlsonIn recent years, this group of top-tier companies has increased its ownership position of the market. At the same time, Kalorama found that there are still opportunities for new companies. Roche and Abbott are world market leaders, according to the firm's report titled "Worldwide Market for In Vitro Diagnostic Tests," published in August.September 10, 2020InfectiousTop 5 facts about the IVD marketBy Bruce CarlsonAmong other information and individual test segment reporting in the more than 1,800 page report were the following five facts:August 31, 2020Klebsiella PneumoniaeT2Bacteria panel proves itself, but will hospitals buy in?By Emily HayesThe prospective study of 1,427 patients in 11 centers tested the sensitivity, specificity, and speed of the T2Bacteria panel, which is an insert for T2 Biosystems' T2Dx miniaturized magnetic resonance instrument. The system directly tests blood for five types of bacteria ("ESKAPE pathogens") that cause bloodstream infections (BSI): Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli.May 13, 2019Fungal InfectionsLabs gear up to diagnose novel fungal infectionBy Bruce CarlsonIn the past few years, more than 600 cases of an emerging fungal infection called Candida auris have been identified in 12 U.S. states, according to the CDC.April 14, 2019
